Skip to content
Z Zendikt
Editorial verdict · Who it’s wrong for

Who shouldn’t buy UiPath?

A direct read on the buyers UiPath is the wrong fit for — sourced from the same editorial team that ranked the full Robotic Process Automation (RPA) category.

Worst for

SMBs without dedicated automation teams (Power Automate cheaper and good-enough), Microsoft-anchored shops where the M365 E5 bundle covers most use cases, or buyers wanting AI-agent-first architecture without legacy-RPA pricing baggage (covered separately in AI Agent Platforms).

For context: who it IS for

Large enterprises (1,000-100,000+ employees) with serious RPA programs already running 50+ bots, organizations that need a deep, mature, multi-modal automation platform and can absorb the strategic risk of UiPath being mid-pivot from classic RPA to AI-agent orchestration.

Target size: 1,000–100,000+ · Large enterprises with dedicated automation CoEs

Why we say this

Editorial pulled these weaknesses from UiPath’s product card in our Top 10 RPA Software for 2026:

  • ! Stock down ~80% from 2021 IPO peak through 2024
  • ! Multiple layoff rounds and exec churn 2023-2024
  • ! Aggressive expansion-quota motion during 2024 retention crunch
  • ! Pricing complexity (Studio + Orchestrator + bots + AI Center stack pricing opaque)
  • ! Classic-RPA renewal pricing pressure as AI-agent platforms compete
  • ! Annual price increases of 8-12% routinely flagged

If UiPath is wrong for you, consider these instead

Same Robotic Process Automation (RPA) category, different best-fit buyer.

Related editorial

Last updated 2026-05-09. Editorial verdict based on the published Top 10 RPA Software for 2026 ranking. Disagree? Tell us.